文献速递腹部USMR

双对比增强超声提高胰腺尾部隐匿性病变的检出与定位:初步经验报告

Double contrast-enhanced ultrasound improves the detection and localization of occult lesions in the pancreatic tail: a initial experience report.
PubMed 文献 · Abdom Radiol (NY) · 2019-01-01

本研究纳入35例临床或MRI怀疑胰腺隐匿性病变的患者,行双对比增强超声(DCEUS)检查,比较常规超声、DCEUS与MRI对胰腺尾部肿瘤的检出能力。DCEUS对≤2.2 cm隐匿性病变的敏感度和特异度分别为92%和95%,常规超声为67%和66%,MRI为91%和88%;DCEUS各期开始时间明显早于MRI对应期。

要点

  • DCEUS对≤2.2 cm胰腺尾部隐匿性病变的敏感度92%、特异度95%。
  • 常规经腹超声在35例中漏诊11例胰腺尾部肿瘤。
  • DCEUS与MRI的三期显示清晰度评分无显著差异(P > 0.05)。

核心结论

  • DCEUS在检出胰腺尾部隐匿性肿瘤方面是一项有前景的技术,对部分周边病变可能优于动态增强MRI。

研究设计与样本

  • 初步经验报告,纳入35例经MRI或临床证据怀疑胰腺隐匿性病变的患者行胰腺DCEUS检查,由放射科医师评估常规超声、DCEUS和MRI的增强期相、肿瘤存在、位置、增强特征和肿瘤显示清晰度。

关键影像表现/征象

  • 常规经腹超声在35例中漏诊11例胰腺尾部肿瘤。
  • DCEUS在35例中显示12个病灶。
  • MRI在35例中识别出10例胰腺尾部肿瘤。
  • DCEUS各期开始时间明显早于MRI对应期相。

诊断标准与关键数值

  • DCEUS对≤2.2 cm隐匿性病变的敏感度为92%、特异度为95%。
  • 常规超声的敏感度为67%、特异度为66%。
  • MRI的敏感度为91%、特异度为88%。
  • 肿瘤显示清晰度采用四点量表评分,DCEUS与MRI组间三个期相的清晰度评分无显著差异(P > 0.05)。

临床应用与阅片要点

  • 对临床或MRI怀疑胰腺尾部隐匿性病变者,DCEUS可作为术前检出与定位的补充检查。
  • DCEUS各期开始时间早于MRI对应期相,阅片时需注意期相时间差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: The aim of this study is to review our initial experience of Double contrast-enhanced ultrasonography (DCEUS) in the preoperative detection of pancreatic tail occult tumors.

METHODS: Thirty-five patients were recruited to undergo DCEUS of the pancreas suspected by occult lesions of pancreatic with MRI or clinical evidence. The radiologists assessed the images (conventional US, DCEUS, and MRI) for enhancement phases, tumor presence, location, enhancement characteristics, and tumor conspicuity. The differences in the onset times of the phases between DCEUS and MRI were noted. Tumor conspicuity was graded on a four-point scale for conspicuity comparison among three imaging modalities.

RESULTS: Pancreatic tail tumors were missed on conventional transabdominal US in 11 of 35 patients. DCEUS revealed 12 lesions of 35 patients. Pancreatic tail tumors were identified on MRI in 10 of 35 patients. The sensitivity and specificity of DCEUS for depicting occult lesions of ≤ 2.2 cm were 92% and 95%, respectively. In contrast, the sensitivity and specificity of conventional US were 67% and 66%, respectively. The sensitivity and specificity of MRI were 91% and 88%, respectively. The conspicuity ratings of the three phases did not significantly differ between the DCEUS and MRI groups (P > 0.05). The DCEUS phases started much earlier than the corresponding MRI phases.

CONCLUSION: DCEUS is a promising technique in the detection of occult pancreatic tail tumors and is possibly superior to dynamic enhanced MRI in the case of some peripheral lesions.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Zhu W, Mai G, Zhou X, et al. Double contrast-enhanced ultrasound improves the detection and localization of occult lesions in the pancreatic tail: a initial experience report. Abdom Radiol (NY). 2019. PMID: 30121778. doi:10.1007/s00261-018-1746-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。